Work

Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer

FWCI: 0.474
Cites:
Cited by: 6
Related to: 10